Breast Imaging in the Era of Molecular Medicine
Monday, Nov. 29, 8:30 AM - 12:00 PM
Presenters are sharing a host of studies that indicate the value and evolving role of molecular imaging in breast imaging. Topics include: molecular pathways that define breast cancer subtypes, applications of screening and diagnostic molecular breast imaging, therapeutic monitoring with PET/CT, pre-surgical planning with MRI and much more. The session is concluding with a panel discussion of the future of breast imaging.
The speakers are:
- Robyn L. Birdwell, MD, director, breast imaging, Dana-Farber Cancer Institute in Boston; and
- Homer A. Macapinlac, MD, professor, nuclear medicine, MD Anderson Cancer Center in Houston.